久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Health collaborations forged at CIIE begin to bear fruit

By ZHOU WENTING in Shanghai | China Daily | Updated: 2021-01-19 10:10
Share
Share - WeChat
The stall of Novo Nordisk at the third China International Import Expo in Shanghai. [Photo/Xinhua]

Medical procedures, drugs, online programs serve patients, public across country

Two months after the third China International Import Expo ended in Shanghai, some exhibitors from the healthcare sector have disclosed that collaborations forged during the event have now materialized in the form of new drugs, innovative systems and technologies benefiting patients and the general public.

It transpires that several agreements were clinched between pharmaceutical multinationals and local healthcare authorities, institutions, schools and enterprises during the third CIIE.

Their partnerships' objective is to exploit inherent advantages and synergies in order to make the healthcare ecosystem in the country more innovative.

Executives of US-headquartered Boston Scientific said they had forged a strategic collaboration with Vivolight, a medical imaging device and technology provider based in Shenzhen, Guangdong province, during the third CIIE.

Their partnership may help drive improved clinical outcomes and technological progress in percutaneous coronary intervention, or PCI, procedures at hospitals.

This is said to be the first-ever strategic cooperation between a foreign enterprise and a local counterpart in the field of coronary intervention imaging.

The collaboration combines Boston Scientific's advantage in intravascular ultrasound and Vivolight's competitiveness in optical coherence tomography to provide patients with more accurate medical solutions for better treatment.

Experts said PCI procedures guided by imaging techniques such as IVUS and vascular OCT can significantly reduce the incidence of serious adverse events by making up for the lack of coronary angiography.

Industry experts said IVUS applied in intervention has been regarded as the "gold standard" in accordance with guidance from Europe and the United States.

However, in China, only 8 percent of PCI procedures are guided by imaging techniques, which compares with 15 percent in the US and more than 90 percent in Japan.

"For Boston Scientific, an important impetus of continuous growth in the China market is to collaborate with local partners to satisfy more local patients' unmet needs through diversified innovative channels," the company said in a written reply.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 欧美日韩精品一区二区三区视频在线 | 国产午夜精品理论片在线 | 豆国产97在线 | 亚洲 | 国产免费一级在线观看 | 一级片在线观看视频 | 久久狠狠一本精品综合网 | 波多野结衣中文在线播放 | 久香草视频在线观看 | 亚洲美女视频在线 | 欧美透逼视频 | 98国内自拍在线视频 | 色三级大全高清视频在线观看 | 成人a毛片一级 | 日本加勒比系列 | 一级毛片无毒不卡直接观看 | 久久久久久全国免费观看 | 日本黄色大片在线播放视频免费观看 | 又黄又爽视频好爽视频 | 国产99久久精品 | 国产精品一区二区三区四区五区 | 美女视频黄色网址 | 国产亚洲欧美日韩国产片 | 97精品国产手机 | 最近日本免费观看视频 | 美女毛片免费 | 日本一级特黄高清ab片 | 一级特黄特色的免费大片视频 | 亚洲欧美精品中文字幕 | 91丨九色丨首页在线观看 | 香蕉视频黄在线观看 | 香蕉网站狼人久久五月亭亭 | 亚洲欧美极品 | 色妇女影院| 日本亚洲欧美国产日韩ay高清 | 欧美专区在线视频 | 嫩草影院在线观看网站成人 | 8888奇米四色在线 | 亚洲精品免费在线观看 | 99国内精品久久久久久久 | 好看欧美视频高清va | 欧美日韩亚洲第一页 |